Evaluating the utility of ZNF331 promoter methylation as a prognostic and predictive marker in stage III colon cancer: results from CALGB 89803 (Alliance)
- Citation:
- Epigenetics vol 19 (1)
- Year:
- 2024
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub-ppub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- Yes
- Book Volume:
- 13
- Parents:
- 3891
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U24CA196171, UG1CA233180, UG1CA233328, UG1CA233339, UG1CA233373; P30-CA015704-44, R50CA233042, T32 CA009515, P30CA15704, UO1CA152756, RO1CA220004, UO1AG077920, U2CCA271902
- Corr. Author:
- Authors:
- Elizabeth S. Nakasone Tyler J. Zemla Ming Yu She Yu Lin Fang-Shu Ou Kelly Carter Federico Innocenti Leonard Saltz William M. Grady Stacey A. Cohen
- Networks:
- HAWAII, LAPS-MN026, LAPS-NC007, LAPS-NY016, NY167
- Study
- CALGB-89803
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: